The median tumor mutation burden (TMB) for ROS1+ NSCLC was 4, the mean was 4.8 (SD 2.8, range 0–15) and only 4.6% of ROS1+ NSCLC tumors had TMB >  = 10. This evidence concerns the gene ROS1 and neoplasm.